NYSE:NNVC

Nanoviricides Stock Insider Trading

Healthcare > Biotechnology

Buy NNVC

*Your capital is at risk

$1.31

-0.0100 (-0.758%)

At Close: Jun 23, 2026

NanoViricides Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 18.35M and sold 1.63M NNVC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	18.35M shares
● Sell	1.63M shares
90% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 22, 2015 Buy	Common Stock, par value $0.001 per share M-Exempt	Diwan Anil President	CEO / President	208 771 Value: $73.1K
Sep 18, 2015 Buy	Common Stock Options M-Exempt	Seymour Eugene Chief Executive Officer	CEO / President	142 856 Value: $50.0K
Sep 18, 2015 Buy	Common Stock Options M-Exempt	Seymour Eugene Chief Executive Officer	CEO / President	142 856 Value: $50.0K
Sep 11, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	50 000 Value: $51.0K
Sep 11, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	50 000 Value: $51.0K
Aug 26, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	50 000 Value: $52.5K
Aug 26, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	50 000 Value: $52.5K
Aug 21, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	29 853 Value: $37.3K
Aug 21, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	29 853 Value: $37.3K
Aug 20, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	2 662 Value: $3K
Aug 20, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	2 662 Value: $3K
Aug 19, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	300 Value: $375
Aug 19, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	300 Value: $375
Aug 18, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	2 547 Value: $3K
Aug 18, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	2 547 Value: $3K
Aug 17, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	5 244 Value: $7K
Aug 17, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	5 244 Value: $7K
Aug 14, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	8 594 Value: $10.7K
Aug 14, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	8 594 Value: $10.7K
Aug 13, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	800 Value: $1K
Aug 13, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	800 Value: $1K
Jul 08, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	50 000 Value: $79.0K
Jul 08, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	50 000 Value: $79.0K
Jun 22, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	43 472 Value: $82.6K
Jun 19, 2015 Buy	Common Stock, par value $0.001 P-Purchase	Boniuk Milton Director	Director	6 528 Value: $12.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NANOVIRICIDES, INC

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular...

Read Full Profile Here